Cargando…

Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder: A case report

Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder is usually characterized by nodules and plaques affecting the upper part of the body. The present case presented with a large, single tumor located on a lower extremity. The patient did not respond to surgical therapy but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koper, Monika, Putała‐Pośpiech, Małgorzata, Biernat, Wojciech, Woźniacka, Anna, Robak, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452474/ https://www.ncbi.nlm.nih.gov/pubmed/30997068 http://dx.doi.org/10.1002/ccr3.2018

Ejemplares similares

Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
por: Valentim, Flávia de Oliveira, et al.
Publicado: (2019)

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder in an Unusual Location
por: Ruiz-Sánchez, Daniel, et al.
Publicado: (2022)

An Atypical Presentation of Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder
por: Kazan, Didem, et al.
Publicado: (2023)

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors()
por: Sarac, Esra, et al.
Publicado: (2023)

Differential diagnosis of primary cutaneous CD4+ small/medium T-cell lymphoproliferative lesions: A report of three cases
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
por: Escanilla, Claudio, et al.
Publicado: (2019)

Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
por: Dimassi, Ahmad B, et al.
Publicado: (2020)

Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019)

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021)

Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma
por: MA, Han, et al.
Publicado: (2016)

Neurolymphomatosis in Primary Cutaneous CD4+ Pleomorphic Small/Medium-sized T-cell Lymphoma Mimicking Hansen's Disease
por: Khader, Anza, et al.
Publicado: (2017)

Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma Following Heart Transplantation
por: Shakerian, B., et al.
Publicado: (2017)

CD30+ Primary Cutaneous Post-transplant Lymphoproliferative Disorder with Signet-ring Cell Features
por: Malviya, Neeta, et al.
Publicado: (2016)

Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
por: Robak, Tadeusz, et al.
Publicado: (2009)

Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report
por: Kim, Jeenam, et al.
Publicado: (2021)

Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4+
por: Ardeleanu, Valeriu, et al.
Publicado: (2022)

Methotrexate use and NAD(+)/NADH metabolism in psoriatic keratinocytes
por: Liszewska, Agata, et al.
Publicado: (2020)

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.
por: Wozniacka, Anna, et al.
Publicado: (2003)

Macular function in patients with medium myopia
por: Grudzińska, Ewa Małgorzata, et al.
Publicado: (2022)

The enigmatic ear: Unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review
por: Sahraoui, Ghada, et al.
Publicado: (2023)

The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosus
por: Tokarska, Kamila, et al.
Publicado: (2019)

Psoriatic Arthritis: Development, Detection and Prevention: A Scoping Review
por: Kimak, Agnieszka, et al.
Publicado: (2023)

Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil
por: Ferreira, Cristiane Rúbia, et al.
Publicado: (2019)

Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder
por: Kadin, Marshall E., et al.
Publicado: (2020)

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
por: Gentile, Michelle S., et al.
Publicado: (2015)

Entrepreneurship in small and medium-sized enterprises
por: Masouras, Andreas
Publicado: (2019)

Effect size – large, medium, and small
por: Leppink, Jimmie, et al.
Publicado: (2016)

Primary pulmonary lymphoproliferative neoplasms
por: Tang, Victoria K, et al.
Publicado: (2018)

Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient
por: Wang, Hua Xian Elizabeth, et al.
Publicado: (2022)

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (2004)

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration
por: Hawro, Tomasz, et al.
Publicado: (2010)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity
por: Saleh, Jamal Z., et al.
Publicado: (2016)

The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
por: Al-Zubaidi, Hanaan Kareem, et al.
Publicado: (2023)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Work-Related Psychosocial Stress in Small and Medium-Sized Enterprises: An Integrative Review
por: Schreibauer, Elena Christina, et al.
Publicado: (2020)

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes
por: Robak, E., et al.
Publicado: (1996)

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus
por: Kaleta, Beata, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nhab98im6ujjj90u2vr03ovhl1